Automated In-House Radiosynthesis Yields High-Purity Prostate Cancer Theranostic Agent Equivalent to Commercial Drug
Researchers have validated an automated in-house radiosynthesis protocol that produces lutetium-177-labeled PSMA-617 with high purity and biological stability comparable to ...


